#astellas — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #astellas, aggregated by home.social.
-
Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas
With all the fretting from the pharmaceutical industry about competition from China, patent protection losses, price reduction initiatives…
#France #FR #Europe #EU #Sanofi #Astellas #BoehringerIngelheim #BristolMyersSquibb #DaiichiSankyo #Dupixent #EliLilly #FiercePharmaHomepage #NovoNordisk #pharma #QuarterlySales #RegeneronPharmaceuticals #Takeda
https://www.europesays.com/france/64664/ -
Neural dust can READ your neural signals wirelessly. StimDust can WRITE new ones. DARPA funds it. Pharma owns it. NATO plans for it.
And there is zero regulatory framework to stop it.
This is not a conspiracy theory. It is peer-reviewed, patented, and funded.
https://thomaster.substack.com/p/the-1b-race-to-wirelessly-read-and
#NeuralDust #StimDust #BrainComputerInterface #DARPA #NATO #CognitiveWarfare #Neurorights #NeuralPrivacy #BCI #Neurotechnology #HavanaSyndrome #DirectedEnergy #Astellas #IotaBiosciences #MentalPrivacy
-
Neural dust can READ your neural signals wirelessly. StimDust can WRITE new ones. DARPA funds it. Pharma owns it. NATO plans for it.
And there is zero regulatory framework to stop it.
This is not a conspiracy theory. It is peer-reviewed, patented, and funded.
https://thomaster.substack.com/p/the-1b-race-to-wirelessly-read-and
#NeuralDust #StimDust #BrainComputerInterface #DARPA #NATO #CognitiveWarfare #Neurorights #NeuralPrivacy #BCI #Neurotechnology #HavanaSyndrome #DirectedEnergy #Astellas #IotaBiosciences #MentalPrivacy
-
https://www.europesays.com/ch/86909/ Takeda, Innovent-Lilly, Roche—Fierce Pharma Asia #Asia #Astellas #BiotechnologyInnovationOrganization #BoehringerIngelheim #china #Chugai #Eisai #FDA #FiercePharmaAsia #FiercePharmaHomepage #Form483 #GLP1 #InnoventBiologics #KyowaKirin #Lenvima #Leqembi #LicensingDeals #Pharma #Roche #SamsungBioepis #Takeda #WuXiAppTec
-
https://www.europesays.com/ch/86776/ OX40, Roche-Sanegene, Daiichi—Fierce Pharma Asia #Amgen #AntibodyDrugConjugates #ArtificialIntelligence #Asia #Astellas #Chugai #DaiichiSankyo #Datroway #FiercePharmaAsia #FiercePharmaHomepage #India #KyowaKirin #Pharma #RNAInterference(RNAi) #Roche #SunPharmaceutical #Vyloy
-
🔥 TRENDING
📢 لماذا تتراجع أسهم Astellas Pharma اليوم؟ - Investing.com
#Astellas #Pharma #Investing.com #GlobalFeed #News #ARABIC
*Automatically posted by Global Feed Bot*
-
🔥 TRENDING
📢 لماذا تتراجع أسهم Astellas Pharma اليوم؟ - Investing.com
#Astellas #Pharma #Investing.com #GlobalFeed #News #ARABIC
*Automatically posted by Global Feed Bot*
-
🔥 TRENDING
📢 لماذا تتراجع أسهم Astellas Pharma اليوم؟ - Investing.com
#Astellas #Pharma #Investing.com #GlobalFeed #News #ARABIC
*Automatically posted by Global Feed Bot*
-
🔥 TRENDING
📢 لماذا تتراجع أسهم Astellas Pharma اليوم؟ - Investing.com
#Astellas #Pharma #Investing.com #GlobalFeed #News #ARABIC
*Automatically posted by Global Feed Bot*
-
https://www.europesays.com/es/430848/ Expertos apuestan por anticipar el riesgo de rechazo antes del trasplante para mejorar los resultados #Astellas #C1 #ES #España #Health #Investigación #Salud #set #Spain #trasplantes
-
https://www.europesays.com/es/390321/ La imagen avanzada y la medicina de precisión transforman el abordaje del cáncer de próstata y vejiga #Actualidad #Astellas #C1 #CáncerDePróstata #CáncerDeVejiga #ES #España #Health #Oncología #Salud #SEOR #Spain
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Astellas Pharma is seeking approval for eye treatment Izervay in Japan and Europe, a bid to expand sales to counter a potential revenue drop for its top cancer medicine. https://www.japantimes.co.jp/business/2024/06/11/companies/astellas-eye-drug-japan-approval/ #business #companies #astellas #pharmaceuticals #medicine
-
Astellas Pharma is seeking approval for eye treatment Izervay in Japan and Europe, a bid to expand sales to counter a potential revenue drop for its top cancer medicine. https://www.japantimes.co.jp/business/2024/06/11/companies/astellas-eye-drug-japan-approval/ #business #companies #astellas #pharmaceuticals #medicine
-
Astellas Pharma is seeking approval for eye treatment Izervay in Japan and Europe, a bid to expand sales to counter a potential revenue drop for its top cancer medicine. https://www.japantimes.co.jp/business/2024/06/11/companies/astellas-eye-drug-japan-approval/ #business #companies #astellas #pharmaceuticals #medicine
-
Astellas Pharma is seeking approval for eye treatment Izervay in Japan and Europe, a bid to expand sales to counter a potential revenue drop for its top cancer medicine. https://www.japantimes.co.jp/business/2024/06/11/companies/astellas-eye-drug-japan-approval/ #business #companies #astellas #pharmaceuticals #medicine
-
Astellas Pharma is seeking approval for eye treatment Izervay in Japan and Europe, a bid to expand sales to counter a potential revenue drop for its top cancer medicine. https://www.japantimes.co.jp/business/2024/06/11/companies/astellas-eye-drug-japan-approval/ #business #companies #astellas #pharmaceuticals #medicine
-
GSK raises profit outlook on strong vaccine, HIV drug sales—Pfizer beats Q1 forecast despite 20% revenue drop, cuts four pipeline programs —Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal--http://bit.ly/w28kSd #earnings #gsk #pfizer #hiv #vaccines #celltherapy #astellas #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
GSK raises profit outlook on strong vaccine, HIV drug sales—Pfizer beats Q1 forecast despite 20% revenue drop, cuts four pipeline programs —Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal--http://bit.ly/w28kSd #earnings #gsk #pfizer #hiv #vaccines #celltherapy #astellas #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Japanese Ambassador to China Kenji Kanasugi on Tuesday met with a Japanese employee of Astellas Pharma who has been detained by Chinese authorities on suspicion of espionage, diplomatic sources said. https://www.japantimes.co.jp/news/2024/03/26/japan/detained-astellas-worker-envoy-meet/ #japan #china #astellas #espionage #chinajapanrelations
-
Japanese Ambassador to China Kenji Kanasugi on Tuesday met with a Japanese employee of Astellas Pharma who has been detained by Chinese authorities on suspicion of espionage, diplomatic sources said. https://www.japantimes.co.jp/news/2024/03/26/japan/detained-astellas-worker-envoy-meet/ #japan #china #astellas #espionage #chinajapanrelations
-
Japanese Ambassador to China Kenji Kanasugi on Tuesday met with a Japanese employee of Astellas Pharma who has been detained by Chinese authorities on suspicion of espionage, diplomatic sources said. https://www.japantimes.co.jp/news/2024/03/26/japan/detained-astellas-worker-envoy-meet/ #japan #china #astellas #espionage #chinajapanrelations
-
Japanese Ambassador to China Kenji Kanasugi on Tuesday met with a Japanese employee of Astellas Pharma who has been detained by Chinese authorities on suspicion of espionage, diplomatic sources said. https://www.japantimes.co.jp/news/2024/03/26/japan/detained-astellas-worker-envoy-meet/ #japan #china #astellas #espionage #chinajapanrelations
-
Japanese Ambassador to China Kenji Kanasugi on Tuesday met with a Japanese employee of Astellas Pharma who has been detained by Chinese authorities on suspicion of espionage, diplomatic sources said. https://www.japantimes.co.jp/news/2024/03/26/japan/detained-astellas-worker-envoy-meet/ #japan #china #astellas #espionage #chinajapanrelations
-
GSK buying Aiolos for $1.4B to boost asthma pipeline —Bristol Myers Squibb CEO Boerner emphasizes organic pipeline over recent M&A deals— FDA declines to approve Astellas' gastric cancer drug --http://bit.ly/w28kSd #gsk #asthma #mergersandacquisitions #bristolmyerssquibb #fda #gastriccancer #astellas #jpmhc24 #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
After a record run, fewer biotechs are going public-- Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer— 8 medtech trends to watch in 2024 --http://bit.ly/w28kSd #ipos #merck #astellas #pfizer #bladdercancer #medtech #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field-- Biopharma’s top 5 IPOs of 2023 so far --Astellas builds case for menopause drug fezolinetant http://bit.ly/w28kSd #abbvie #mergersandacquisitions #immunogen #ipos #menopause #astellas #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff -- Vertex, CRISPR win world’s first approval for CRISPR-edited therapy from UK --BMS gets US approval for ROS1 lung cancer drug Augtyro-- See more on our front page news http://bit.ly/w28kSd #astellas #vertexpharma #crispr #geneediting #bristolmyerssquibb #lungcancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer-- BrainStorm eyes FDA meeting to find path for rejected ALS drug after withdrawing application --Amazon will start delivering prescriptions by drone -- See more on our front page news http://bit.ly/w28kSd #seagen #astellas #merck #keytruda #esmo #bladdercancer #als #fda #amazon #drones #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Why a hidden message in Ozempic’s logo represents a big shift in drug branding -- Merck, Seagen, and Astellas get late-stage win in bladder cancer -- Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses -- See more on our front page news http://bit.ly/w28kSd #ozempic #logo #novonordisk #branding #merck #seagen #astellas #bladdercancer #clinicaltrials #eisai #lungcancer #keytruda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Massachusetts' biotech job boom -- Astellas withdraws lawsuit challenging Medicare drug price negotiation plans -- Pfizer ticks off Lyme vaccine milestone -- See more on our front page news http://bit.ly/w28kSd #massachusetts #astellas #medicare #drugpricing #inflationreductionact #lymedisease #vaccines #clinicaltrials #pfizer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Biogen to eliminate 1,000 jobs in further cost cuts -- Cognizant, Gilead extend service agreement worth $800M -- Astellas notches another protein degrader pact with $21M upfront for PeptiDream -- See more on our front page news http://bit.ly/w28kSd #biogen #layoffs #gileadsciences #astellas #proteindegradation #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
On Tuesday, #Johnson & #Johnson became the latest drugmaker to take the Biden administration to federal court in an attempt to put a #halt to the #drug #pricing #program. Three other drug companies — #Merck, #Bristol #Myers #Squibb and #Astellas #Pharma — have filed their own lawsuits, as have the industry’s main trade group and the U.S. #Chamber of #Commerce.
The suits make similar and overlapping claims that the drug pricing provisions are #unconstitutional. They are scattered in federal courts around the country — a tactic that experts say gives the industry a better chance of obtaining #conflicting #rulings that will put the legal challenges on a fast track to a business-friendly #Supreme #Court.
-
On Tuesday, #Johnson & #Johnson became the latest drugmaker to take the Biden administration to federal court in an attempt to put a #halt to the #drug #pricing #program. Three other drug companies — #Merck, #Bristol #Myers #Squibb and #Astellas #Pharma — have filed their own lawsuits, as have the industry’s main trade group and the U.S. #Chamber of #Commerce.
The suits make similar and overlapping claims that the drug pricing provisions are #unconstitutional. They are scattered in federal courts around the country — a tactic that experts say gives the industry a better chance of obtaining #conflicting #rulings that will put the legal challenges on a fast track to a business-friendly #Supreme #Court.
-
On Tuesday, #Johnson & #Johnson became the latest drugmaker to take the Biden administration to federal court in an attempt to put a #halt to the #drug #pricing #program. Three other drug companies — #Merck, #Bristol #Myers #Squibb and #Astellas #Pharma — have filed their own lawsuits, as have the industry’s main trade group and the U.S. #Chamber of #Commerce.
The suits make similar and overlapping claims that the drug pricing provisions are #unconstitutional. They are scattered in federal courts around the country — a tactic that experts say gives the industry a better chance of obtaining #conflicting #rulings that will put the legal challenges on a fast track to a business-friendly #Supreme #Court.
-
On Tuesday, #Johnson & #Johnson became the latest drugmaker to take the Biden administration to federal court in an attempt to put a #halt to the #drug #pricing #program. Three other drug companies — #Merck, #Bristol #Myers #Squibb and #Astellas #Pharma — have filed their own lawsuits, as have the industry’s main trade group and the U.S. #Chamber of #Commerce.
The suits make similar and overlapping claims that the drug pricing provisions are #unconstitutional. They are scattered in federal courts around the country — a tactic that experts say gives the industry a better chance of obtaining #conflicting #rulings that will put the legal challenges on a fast track to a business-friendly #Supreme #Court.
-
On Tuesday, #Johnson & #Johnson became the latest drugmaker to take the Biden administration to federal court in an attempt to put a #halt to the #drug #pricing #program. Three other drug companies — #Merck, #Bristol #Myers #Squibb and #Astellas #Pharma — have filed their own lawsuits, as have the industry’s main trade group and the U.S. #Chamber of #Commerce.
The suits make similar and overlapping claims that the drug pricing provisions are #unconstitutional. They are scattered in federal courts around the country — a tactic that experts say gives the industry a better chance of obtaining #conflicting #rulings that will put the legal challenges on a fast track to a business-friendly #Supreme #Court.
-
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board? —FDA advisers narrowly vote in favor of Sarepta's DMD gene therapy —Astellas' menopause drug scores FDA approval, after regulatory setback -- See more on our front page news http://bit.ly/w28kSd #pfizer #seagen #antitrust #mergersandacquisitions #fda #hotflashes #genetherapy #menopause #astellas #dmd #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Astellas to acquire eye drug developer Iveric Bio for $5.9B —With negative FDA panel vote, AstraZeneca's Lynparza looks set for narrow nod in prostate cancer—Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify -- See more on our front page news http://bit.ly/w28kSd #astellas #mergersandacquisitions #eyehealth #fda #prostatecancer #astrazeneca #abilify #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
#Menopause Mongering Returns, Big Time
by Martha Rosenberg, April 3, 2023
"Why the revival? The drug company #Astellas just received a new drug application for fezolinetant, a drug to treat '#VMS' and selling the disease to create 'demand' for a drug is a time honored drug maker tradition. It is buttressed by online 'quizzes' and 'symptom checkers' to help patients self-diagnose the sold condition and go to the doctor requesting the new drug. 'Unbranded' advertising, in which a disease rather than a drug is sold, is often mistaken for messages from the CDC by the public which helps the sell."
Read more: https://www.counterpunch.org/2023/04/03/menopause-mongering-returns-big-time/
https://www.counterpunch.org/2023/04/03/menopause-mongering-returns-big-time/
-
#Menopause Mongering Returns, Big Time
by Martha Rosenberg, April 3, 2023
"Why the revival? The drug company #Astellas just received a new drug application for fezolinetant, a drug to treat '#VMS' and selling the disease to create 'demand' for a drug is a time honored drug maker tradition. It is buttressed by online 'quizzes' and 'symptom checkers' to help patients self-diagnose the sold condition and go to the doctor requesting the new drug. 'Unbranded' advertising, in which a disease rather than a drug is sold, is often mistaken for messages from the CDC by the public which helps the sell."
Read more: https://www.counterpunch.org/2023/04/03/menopause-mongering-returns-big-time/
https://www.counterpunch.org/2023/04/03/menopause-mongering-returns-big-time/
-
#Menopause Mongering Returns, Big Time
by Martha Rosenberg, April 3, 2023
"Why the revival? The drug company #Astellas just received a new drug application for fezolinetant, a drug to treat '#VMS' and selling the disease to create 'demand' for a drug is a time honored drug maker tradition. It is buttressed by online 'quizzes' and 'symptom checkers' to help patients self-diagnose the sold condition and go to the doctor requesting the new drug. 'Unbranded' advertising, in which a disease rather than a drug is sold, is often mistaken for messages from the CDC by the public which helps the sell."
Read more: https://www.counterpunch.org/2023/04/03/menopause-mongering-returns-big-time/
https://www.counterpunch.org/2023/04/03/menopause-mongering-returns-big-time/
-
#Menopause Mongering Returns, Big Time
by Martha Rosenberg, April 3, 2023
"Why the revival? The drug company #Astellas just received a new drug application for fezolinetant, a drug to treat '#VMS' and selling the disease to create 'demand' for a drug is a time honored drug maker tradition. It is buttressed by online 'quizzes' and 'symptom checkers' to help patients self-diagnose the sold condition and go to the doctor requesting the new drug. 'Unbranded' advertising, in which a disease rather than a drug is sold, is often mistaken for messages from the CDC by the public which helps the sell."
Read more: https://www.counterpunch.org/2023/04/03/menopause-mongering-returns-big-time/
https://www.counterpunch.org/2023/04/03/menopause-mongering-returns-big-time/
-
#Menopause Mongering Returns, Big Time
by Martha Rosenberg, April 3, 2023
"Why the revival? The drug company #Astellas just received a new drug application for fezolinetant, a drug to treat '#VMS' and selling the disease to create 'demand' for a drug is a time honored drug maker tradition. It is buttressed by online 'quizzes' and 'symptom checkers' to help patients self-diagnose the sold condition and go to the doctor requesting the new drug. 'Unbranded' advertising, in which a disease rather than a drug is sold, is often mistaken for messages from the CDC by the public which helps the sell."
Read more: https://www.counterpunch.org/2023/04/03/menopause-mongering-returns-big-time/
https://www.counterpunch.org/2023/04/03/menopause-mongering-returns-big-time/
-
FDA approves Keytruda/Padcev combo in advanced urothelial cancer — Record growth in U.S. life sciences real estate footprint — Diabesity drugs and their free ‘contract sales force’ -- See more on our front page news http://bit.ly/w28kSd #fda #merck #astellas #urothelialcancer #realestate #diabetes #obesity #novonordisk #elililly #keytruda #lifesciences #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
